Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,278,865 |
|
|||||
| News | - | ||||||
| Day High | 0.48 | Low High |
|||||
| Day Low | 0.4376 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Northwest Biotherapeutics Inc (QB) | NWBO | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -2.17% | 0.45 | 16:30:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.47 | 0.4376 | 0.48 | 0.45 | 0.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 736 | 2,278,865 | $ 0.456433 | $ 1,040,149 | - | 0.4001 - 1.11 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:59 | 21 | $ 0.449 | USD |
Northwest Biotherapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 202.29M | 1.10B | 972.39M | 1.93M | -64.37M | -0.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Northwest Biotherapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NWBO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.495 | 0.5218 | 0.4376 | 0.4643028 | 1,190,230 | -0.045 | -9.09% |
| 1 Month | 0.55 | 0.57 | 0.4376 | 0.4894568 | 1,273,693 | -0.10 | -18.18% |
| 3 Months | 0.584 | 0.6489 | 0.4376 | 0.5288607 | 1,583,926 | -0.134 | -22.95% |
| 6 Months | 0.80 | 0.929 | 0.4376 | 0.6352223 | 1,730,162 | -0.35 | -43.75% |
| 1 Year | 0.57 | 1.11 | 0.4001 | 0.6593564 | 1,846,838 | -0.12 | -21.05% |
| 3 Years | 1.42 | 2.15 | 0.3862 | 0.8505624 | 2,088,899 | -0.97 | -68.31% |
| 5 Years | 0.32 | 2.54 | 0.005 | 0.8513583 | 2,300,772 | 0.13 | 40.63% |
Northwest Biotherapeutics (QB) Description
| Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. |
